Abstract: . . .  with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet . 2002; 359:1004-1010. 35. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular Page 9 S72 complications in type 2 diabetes: UKPDS 39. BMJ . 1998; 317:713-720. 36. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.The Antihypertensive and Lipid-Lowering Treatment . . .
. . .  la Framingham Heart Study et le Cardiovascular Life Expectancy Model est disponible en ligne 8 . Dyslipidmie en prsence de diabte de type 2 La dyslipidmie la plus courante en prsence de diabte de type 2 est une hypertriglycridmie accompagne dun faible taux de C-HDL et dun taux normal de cholestrol des Complications macrovasculaires, dyslipidmie et hypertension Association canadienne du diabte Comit dexperts des Lignes directrices de pratique clinique La version prliminaire de ce chapitre a t rdige par Lawrence A.Leiter,MD,FRCPC,FACP;Jeffrey Mahon,MD, MSc,FRCPC;Teik Chye Ooi,MBBS,FRCPC,FRACP,FACE; Steven Grover,MD,MPA,FRCPC;Maria . . .
. . .  le taux de C-LDL Rsines hypocholestrolmiantes chlorhydrate de colestipol (Colestid ) rsine de cholestyramine (Questran , Questran Lger, mdicament gnrique) Rduction du taux de C-LDL Ont tendance augmenter le taux de TG et ne sont donc pas trs utiles contre la dyslipidmie diabtique Statines (inhibiteurs de lHMG-CoA- rductase) atorvastatine (Lipitor MC ) fluvastatine (Lescol ) lovastatine (Mevacor , mdicament gnrique) pravastatine (Pravachol , mdicament gnrique) rosuvastatine (Crestor )  . . .
. . .  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA .2000;283:1967-1975. 38. Tuomilehto J, Rastenyte D, Birkenhger WH, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension . N Engl J Med . 1999;340:677-684. 39. DiMinno G, Silver MJ, Cerbone AM, et al.Trial of repeated low-dose aspirin in diabetic angiopathy. Blood .1986;68:886-891. 40. Halushka PV,Rogers RC,Loadholt CB,et al.Increased platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med . 1981;97:87-96. 41. Dav G, Catalano I,Averna M, . . .
--3000,4,375,3303,48349